Evidence map›Paper›PMID 34714525›Full record

ArticleInternational journal of hematology2022

Anti-Fy

Takahiro Matsuno, Hideaki Matsuura, Sumie Fujii, Ryoka Suzuki, Yukari Sugiura, Yasuo Miura

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Takahiro Matsuno *Department of Blood Transfusion, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Hideaki Matsuura *Department of Blood Transfusion, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Sumie FujiiDepartment of Transfusion Medicine and Cell Therapy, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Ryoka SuzukiDepartment of Blood Transfusion, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Yukari SugiuraDepartment of Blood Transfusion, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. ysugiura@fujita-hu.ac.jp.
Yasuo MiuraDepartment of Blood Transfusion, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. ymiura@fujita-hu.ac.jp.ORCID http://orcid.org/0000-0001-9654-1300
Fujita Health University Hospital · JP

Funding

Japan Society for the Promotion of Science 21K15655
6 · The paper itself

Abstract

A 43-year-old Japanese male, who had undergone open liver surgery for tumor resection, presented with decreased hemoglobin levels on Day 13 post-emergency-release transfusion of 16 units of Fy(a +) red blood cells. As the anemia was accompanied by increased lactate dehydrogenase, indirect bilirubin, and reticulocytes, as well as decreased haptoglobin, it was attributed to hemolysis. In the diagnostic workup for hemolytic reaction, the direct antiglobulin test result for IgG was positive and the antibody dissociated from the patient's peripheral red blood cells was identified as anti-Fy

Indexed as

HemolysisAdultAllelesAsian PeopleBlood Group IncompatibilityDuffy Blood-Group SystemEmergenciesErythrocyte TransfusionHLA-DRB1 ChainsHumansMalePatient AcuityPhenotypeTime FactorsTransfusion ReactionDuffy Blood-Group SystemHLA-DRB1*04 antigenHLA-DRB1 ChainsDelayed hemolytic transfusion reactionHuman leukocyte antigenIrregular antibodyRed blood cell transfusion

Identifiers

PMID34714525
OpenAlexW3208080294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.